How can ‘Hy's law’ help the clinician?

[1]  P. Moses,et al.  Severe hepatotoxicity associated with bromfenac sodium , 1999, American Journal of Gastroenterology.

[2]  William M. Lee,et al.  Hepatic Findings in Long-Term Clinical Trials of Ximelagatran , 2005, Drug safety.

[3]  J. Senior,et al.  Troglitazone-induced liver failure: a case study. , 2003, The American journal of medicine.

[4]  J. Rabkin,et al.  Fatal Fulminant Hepatitis Associated with Bromfenac Use , 1999, The Annals of pharmacotherapy.

[5]  D J Graham,et al.  Liver enzyme monitoring in patients treated with troglitazone. , 2001, JAMA.

[6]  S. Buskin,et al.  Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. , 1999, JAMA.

[7]  E. Björnsson,et al.  Outcome and prognostic markers in severe drug‐induced liver disease , 2005, Hepatology.

[8]  Luis Rodrigo,et al.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.

[9]  William M. Lee,et al.  Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation , 1999 .

[10]  A. Flahault,et al.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.

[11]  William M. Lee,et al.  Recognizing Drug-Induced Liver Injury: Current Problems, Possible Solutions , 2005, Toxicologic pathology.

[12]  C. Pinson,et al.  Bromfenac(Duract)-associated hepatic failure requiring liver transplantation , 1999, American Journal of Gastroenterology.

[13]  A. Reuben.  Hy's law , 2004, Hepatology.

[14]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[15]  L. Laine,et al.  Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  H. F. Glassner,et al.  Serum Transaminase Levels in Experimental Myocardial Infarction , 1955, Circulation.